ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,105.20
      0.19%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.635
      0.05%
      Bitcoin
      67,138.33
      1.48%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Urovant Sciences Ltd (UROV)

      7. Urovant Sciences Ltd (UROV) News

      UROV

      Urovant Sciences (UROV)

      Urovant Sciences Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:UROV
      DateTimeSourceHeadlineSymbolCompany
      04/13/202212:02PMBusiness WireUrovant Sciences to Present Interim Data from Phase 2a Study of Potential Novel Gene Therapy, URO-902, and New Analyses of Data from Phase 3 EMPOWUR Extension Trial of GEMTESA® (vibegron) 75 mg at 2022 American Urological Association Annual MeetingNASDAQ:UROVUrovant Sciences Ltd
      03/07/202211:56AMBusiness WireUrovant Sciences Announces Positive Topline Results of Phase 2a Trial of its Potential Novel Gene Therapy, URO-902NASDAQ:UROVUrovant Sciences Ltd
      12/20/202112:11PMBusiness WireUrovant Sciences Announces Publication in Advances in Therapy of Analyses of Patient-Perceived Meaningfulness of Improvement in Symptom Reduction for Overactive Bladder Patients Treated with GEMTESA® (vibegron) 75 mgNASDAQ:UROVUrovant Sciences Ltd
      11/08/20218:00AMBusiness WireUrovant Sciences Announces Publication in Blood Pressure Monitoring of Positive Ambulatory Blood Pressure Study Results for GEMTESA® (vibegron) 75 mg in Overactive Bladder PatientsNASDAQ:UROVUrovant Sciences Ltd
      04/01/20216:14AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/31/202112:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UROVUrovant Sciences Ltd
      03/30/202112:13PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:UROVUrovant Sciences Ltd
      03/29/20213:13PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:UROVUrovant Sciences Ltd
      03/29/20213:09PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:UROVUrovant Sciences Ltd
      03/29/20213:06PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:UROVUrovant Sciences Ltd
      03/29/20213:04PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:UROVUrovant Sciences Ltd
      03/29/20218:44AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:UROVUrovant Sciences Ltd
      03/29/20218:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:UROVUrovant Sciences Ltd
      03/24/20214:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:UROVUrovant Sciences Ltd
      02/19/20216:11AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:UROVUrovant Sciences Ltd
      02/19/20216:05AMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:UROVUrovant Sciences Ltd
      02/16/20213:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:UROVUrovant Sciences Ltd
      02/12/20215:43PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:UROVUrovant Sciences Ltd
      02/12/20214:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:UROVUrovant Sciences Ltd
      02/12/20214:05PMBusiness WireUrovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 ResultsNASDAQ:UROVUrovant Sciences Ltd
      02/11/20218:00AMBusiness WireUrovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data & Safety Mon...NASDAQ:UROVUrovant Sciences Ltd
       Showing the most relevant articles for your search:NASDAQ:UROV